BlackRock Advisors’s Acura Pharmaceuticals ACUR Stock Holding History

BlackRock Advisors’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2K	Hold	3,204	–	–	﹤0.01%	3687
2016 Q3	$5K	Hold	3,204	–	–	﹤0.01%	3650
2016 Q2	$6K	Hold	3,204	–	–	﹤0.01%	3655
2016 Q1	$9K	Hold	3,204	–	–	﹤0.01%	3595
2015 Q4	$8K	Hold	3,204	–	–	﹤0.01%	3670
2015 Q3	$8K	Hold	3,204	–	–	﹤0.01%	3685
2015 Q2	$16K	Buy	3,204 +886	+38%	+$3.68K	﹤0.01%	3553
2015 Q1	$9K	Hold	2,318	–	–	﹤0.01%	3545
2014 Q4	$5K	Hold	2,318	–	–	﹤0.01%	3644
2014 Q3	$9K	Hold	2,318	–	–	﹤0.01%	3592
2014 Q2	$13K	Hold	2,318	–	–	﹤0.01%	3539
2014 Q1	$17K	Buy	2,318 +764	+49%	+$6.64K	﹤0.01%	3455
2013 Q4	$13K	Hold	1,554	–	–	﹤0.01%	3481
2013 Q3	$15K	Buy	1,554 +941	+154%	+$8.32K	﹤0.01%	3383
2013 Q2	$6K	Buy	+613	New	+$6.92K	﹤0.01%	3502

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors's ACUR Position: Q4 2016 in Review

BlackRock Advisors held its Acura Pharmaceuticals (ACUR) position steady in Q4 2016 at 3,204 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3687.

BlackRock Advisors first reported a position in ACUR in Q2 2013 and has held it in 15 quarters since. The position peaked at $17K in Q1 2014. 22 funds tracked by Wall St. Rank hold ACUR as of Q4 2016.

BlackRock Advisors held 3,204 shares of Acura Pharmaceuticals worth $2K as of Q4 2016.
BlackRock Advisors left its Acura Pharmaceuticals share count unchanged in Q4 2016.
Acura Pharmaceuticals made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3687 holding.
BlackRock Advisors first reported a position in Acura Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Acura Pharmaceuticals position peaked at $17K in Q1 2014.
22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.